Tag: Pembrolizumab
-
Pembrolizumab Therapy Doubles Survival in Advanced Head and Neck Cancer
Breakthrough Immunotherapy Helps Patients With Locally Advanced Head and Neck Cancer A pivotal advance in the treatment of locally advanced head and neck cancer centers on pembrolizumab, an immunotherapy drug already used in several cancers. In a recent trial, this therapy was integrated into a comprehensive treatment plan that combines surgery, radiotherapy, and chemotherapy, and…
-
Pembrolizumab doubles survival in head and neck cancer: KEYNOTE-689 findings
New hope for locally advanced head and neck cancer: pembrolizumab Locally advanced tumors in the head and neck region pose a formidable challenge. They are often confined to the mucosal areas, yet their proximity to the airway, esophagus, and vital vessels makes surgical removal delicate and potentially mutilating. Radiotherapy and chemotherapy add to the cure…
-
Pembrolizumab Doubles Survival in Advanced Head and Neck Cancer
The Breakthrough: A New Immunotherapy Redefines Outcomes in Locally Advanced Head and Neck Cancer Locally advanced head and neck cancer poses a formidable challenge. In many patients, the disease is detected at a stage where surgery, radiotherapy, and chemotherapy are the mainstays of treatment, yet recurrence and progression remain common. A recent advance in immunotherapy,…